# Angioline to expand medical device production in Novosibirsk

Angioline will build a new 8,500 sq m facility in Koltsovo Biotechnopark for coronary stents and catheters, with investment of 500 million RUB and 250 new jobs. Construction runs 2017-2019, commissioning in 2020.

- Type: Expansion
- Announced: 2017-05-26
- Where: Koltsovo, Novosibirsk Oblast, Russia
- Value: $8.70M (500.0M RUB)
- Jobs: 250
- Starts operating: 2020
- Status: announced
- Products: coronary stents, catheters
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Angioline](https://endata.com/companies/24528.md)

## Sources

- [meditex.ru](https://www.meditex.ru/news_all/news/VNovosibirskezaplanirovanzapuskdvukhkrupnykhmeditsinskikhproizvodstv/), 2017-05-26: "Общая площадь нового здания должна составить 8,5 тыс. кв. м."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.